Financhill
Buy
59

UNCY Quote, Financials, Valuation and Earnings

Last price:
$5.94
Seasonality move :
73.11%
Day range:
$5.92 - $6.30
52-week range:
$3.71 - $11.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.40x
Volume:
526K
Avg. volume:
370.2K
1-year change:
-25.84%
Market cap:
$127.4M
Revenue:
--
EPS (TTM):
-$2.80

Earnings Data

Next earnings date for UNCY
--
Most recent earnings per share
-$0.33
Beat by $0.20
(Sep 30/2025)
Consensus Estimate
-$0.53
(Sep 30/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

UNCY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2025 Q4 -- -- -- -$0.44 --
09/30/2025 Q3 -- -- -$0.33 -$0.53 $0.20
08/14/2025 Q2 -- -- -$0.52 -$0.70 $0.17
05/14/2025 Q1 -- -- -$0.05 -$0.62 $0.57
03/31/2025 Q4 -- -- -$1.89 -$0.70 -$1.19
11/13/2024 Q3 -- -- -$0.05 -$1.52 $1.47
08/14/2024 Q2 -- -- $0.08 -$1.92 $2.00
05/13/2024 Q1 -- -- -$0.61 -$1.55 $0.94
03/28/2024 Q4 -- -- -$0.22 -$1.63 $1.41
11/14/2023 Q3 -- -- -$0.14 -- --
06/30/2023 Q2 -- -- -$0.29 -- --
03/31/2023 Q1 -- $675K -$0.96 -- --
12/31/2022 Q4 -- -- -$0.35 -- --
11/11/2022 Q3 -- $951K -$0.37 -- --
08/16/2022 Q2 -- -- -$0.24 -- --
05/31/2022 Q1 -- -- -$0.24 -- --
02/28/2022 Q4 -- -- -$0.18 -- --
11/11/2021 Q3 -- -- -$0.35 -- --
08/16/2021 Q2 -- -- -$0.08 -- --
03/31/2021 Q1 -- -- -$0.06 -- --
12/31/2020 Q4 -- -- -$0.06 -- --
09/30/2020 Q3 -- -- -$0.05 -- --
06/30/2020 Q2 -- -- -$0.02 -- --
03/31/2020 Q1 -- -- -$0.02 -- --
12/31/2019 Q4 -- -- -$0.05 -- --
09/30/2019 Q3 -- -- -$0.04 -- --

Unicycive Therapeutics, Inc. Earnings Questions

  • How Much did Unicycive Therapeutics, Inc. Generate in Revenue Last Quarter?

    Unicycive Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Unicycive Therapeutics, Inc. Beat Earnings Last Quarter?

    Unicycive Therapeutics, Inc. announced earnings per share of -$0.33 which represents a beat of analyst forecast a -$0.53 per share.

  • Is Unicycive Therapeutics, Inc. Profitable?

    Unicycive Therapeutics, Inc. reported -$148K that represents -$0.01 per share over the last quarter.

  • What is the Analyst Consensus for Unicycive Therapeutics, Inc. EPS Next Year?

    Unicycive Therapeutics, Inc.'s earnings are forecast to decrease from -$5.65 per share to -$5.10 per share next year representing a decrease of -80.85%.

  • When is Unicycive Therapeutics, Inc.'s Earnings Date?

    Currently, Unicycive Therapeutics, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 31, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
14
SMX alert for Dec 30

SMX (Security Matters) Plc [SMX] is down 37.63% over the past day.

Buy
71
ZCSH alert for Dec 30

Grayscale Zcash Trust (ZEC) [ZCSH] is down 1.16% over the past day.

Buy
69
GDXU alert for Dec 30

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 5.52% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock